PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1.70%
Net income growth under 50% of META's 10.17%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
15.12%
D&A growth well above META's 11.33%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-36.74%
Both reduce yoy usage, with META at -271.20%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-36.74%
Negative yoy usage while META is 93.48%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
123.96%
Well above META's 175.76%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
19.48%
Operating cash flow growth above 1.5x META's 6.39%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
65.78%
Some CapEx rise while META is negative at -27.80%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-2.13%
Both yoy lines negative, with META at -95.19%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-1.66%
We reduce yoy sales while META is 198.35%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-237.16%
Both yoy lines negative, with META at -645.56%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-2.26%
Both yoy lines negative, with META at -29.73%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative yoy issuance while META is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.